For the last two years, Dr. Michelle Perro has been in the trenches treating COVID-19 complications, not only from the infection but also from the jab, which is far more problematic and deadly. Perro went to Yale as an undergrad, and then to Mount Sinai Medical School. She completed her postgraduate residency training in pediatrics… Read More »
London, UK – 18 May 2022 – Hampleton Partners, the international M&A and corporate finance advisory firm for technology companies, has advised akquinet enterprise solutions GmbH, a leading provider of SAP cybersecurity & access governance software, on its acquisition by Pathlock backed by New York-based Vertica Capital Partners, a growth-oriented private equity investor with a… Read More »
London, UK and Boston, MA – 11 May 2022 – Evaluate, a leading provider of market intelligence and predictive analytics for the pharmaceutical industry, has today announced that it has appointed Matthew Wright as Chief Financial Officer. Wright will work closely with both the Evaluate and Norstella executive and finance teams as the newly merged… Read More »
BRUSSELS, BELGIUM – 22 April 2022 – Soda, the provider of data reliability tools and observability platform, has been chosen by Americanas S.A., one of Brazil’s largest retailers, to bring trusted data to its rapidly growing retail innovation platform. Soda will provide end-to-end data observability and reliability across Americanas S.A.’s operations, supporting enhanced innovation, automation… Read More »
This story is about a very brave researcher at Columbia University who co-authored a paper on risks associated with COVID vaccination (“vaccine-induced fatality rate”), in October 2021. The researcher’s name is Spiro Pantazatos, Ph.D. He is an Assistant Professor of Clinical Neurobiology (Psychiatry) at Columbia University. He is also Research Scientist at the New York… Read More »